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Background: Novel psychoactive substances (NPS) are continuously and increasingly appearing on the
international drug market. Global Internet forums are a publicly available reality where users anonymously discuss
and share information about NPS. The aim of this study was to explore and characterize the discussions about NPS
on international Internet forums.
Methods: The most post-frequent NPS discussions were collected from three “leading edge” international Internet
forums. A total of 13,082 posts from 60 threads of discussion were systematically examined and interpreted to
reveal recurring topics and patterns. Each thread was coded with emerging topics and supporting quotations from
the data set. Eventually, codes with coherent meaning were arranged into 51 broader categories of abstraction,
which were combined into four overarching themes.
Results: Four themes emerged during the analysis: (1) uncovering the substance facts, (2) dosage and administration,
(3) subjectively experienced effects, and (4) support and safety. The first theme dealt primarily with substance
identification, pharmacology, and assessed not only purity but also legal status and acquisition. The second theme
focused on administration techniques, dose recommendations, technical talk about equipment, and preferred
settings for drug use. The third theme involved a multitude of self-reported experiences, in which many different
aspects of intoxication were depicted in great detail. The users emphasized both positive and negative experiences.
The last theme incorporated the efforts of the communities to prevent and minimize harm by sharing information
about potential risks of the harmful effects or contraindications of a substance. Also, online support and guidance
were given to intoxicated persons who experienced bad or fearful reactions.
Conclusions: The findings showed that the discussions were characterized by a social process in which users
supported each other and exchanged an extensive and cumulative amount of knowledge about NPS and how to
use them safely. Although this publicly available knowledge could entail an increase in drug use, the main
characteristics of the discussions in general were a concern for safety and harm reduction, not for recruiting new
users. Drug-related Internet forums could be used as a location for drug prevention, as well as a source of information
for further research about NPS.
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A profound shift in the market for recreational drugs
has occurred. The availability and number of unregu-
lated novel psychoactive substances (NPS) have continu-
ously increased and expanded into a global phenomenon
[1-3]. For four consecutive years, the European Union
early warning system on drugs has detected a record
high and growing number of new substances and online
vendors. In total, 280 substances, including stimulants,
synthetic cannabinoids, hallucinogens, dissociatives, and
sedatives, are currently being monitored by the Euro-
pean Monitoring Centre for Drugs and Drug Addiction
(EMCDDA). However, NPS prevalence is somewhat un-
certain since the increase of substances could reflect an
improved capacity for detection and monitoring [4].
Moreover, the limited number of demographic studies is
often based on different substances or nonrepresentative
samples and shows varying results across populations
[5-7]. A survey [5] investigating the use of NPS among
youth in Europe found that an average of 5% had experi-
ence of use, a number that differed significantly among
nations. Most sources indicate that users are primarily
young males [8,9], although a recent study [10] reported
that middle-aged adults constituted a quarter of the
sample.
NPS, also referred to as “legal highs”, “designer drugs”,
or “research chemicals”, often mimic the effects of corre-
sponding illicit drugs and are intentionally produced to
circumvent existing drug laws [11]. Legal responses are
to some extent ineffective, partly because clandestine
chemists quickly adapt to and exploit new legislations by
marketing substances with slight molecular deviation
but preserved psychoactive effect [12-14]. In addition,
NPS are often sold surreptitiously as, for example, “bath
salt” or “plant food” and labeled “not for human con-
sumption” in order to avoid legislative attention. Fur-
thermore, the use of the Internet as a marketplace,
rather than the streets, is believed to impede regulatory
actions and promote availability [1].
There are very limited information and published data
on NPS available to either users or health-care personnel
[15,16]. These substances have rarely or never been sub-
jected to studies on humans or animals, which make them
highly unpredictable. Long-term effects, dependency po-
tential, toxicological risks, or possible contraindications
are largely unknown. In addition, content declaration or
warnings about side effects or hazardous substance inter-
actions are mostly lacking [17]. In order to provide know-
ledge of these substances, and patterns of human use, data
from other sources like the Internet have been suggested
and utilized for scientific studies [16,18-20]. For example,
self-reports posted on public Internet forums have been
analyzed to investigate the characteristics of experience
with substances as 4-HO-MET, MXE, and “Spice” [21-23].Although anecdotal data from the Internet have been
claimed to be biased or unreliable [16,19], our recent NPS
study [24] based on Internet discussion forum data
showed that the results were highly congruent with the
findings of studies based on clinical data.
Regardless of the degree of validity, publicly available
content on the Internet is an undeniable reality, which
remains the major source of information for youths with
sensitive or health- and drug-related issues of concern
[5,25,26]. Internet discussion forums provide a global
and anonymous environment in which sharing of drug-
related information is a prominent feature. Other docu-
mented forum characteristics include social cohesion
and support, as well as a focus on harm reduction
[27,28]. Another study [21] has also emphasized the so-
cial togetherness among closed groups of NPS users,
which highlights a need to share and discuss with peers.
Hence, there are strong reasons to further investigate
drug-related Internet communities and the ongoing dis-
cussions in greater depth. It is important to examine
what users are talking about explicitly, as well as investi-
gating any implicit features of the discussions in general,
not only to understand the reality facing young people
online but also to examine the possibilities for future re-
search and prevention strategies.
The aim of this study was to explore, define, and
characterize the discussions about novel psychoactive
substances on international Internet forums.
Methods
Data collection
The data were retrieved from the “leading edge” Internet
forums, as presented by the Psychonaut Web Mapping
Project [19], which identified the key online resources
for the study of NPS. Three internationally oriented dis-
cussion forums with open access were found by Deluca
et al. [19]: bluelight.org, drugs-forum.com, and legal-
highsforum.com. No scientific or anecdotal evidence
that contradicts the status of these sites as “leading edge”
was found. Therefore, all three were considered up-to-
date and included as source of data in the present study.
The 20 most recent threads of discussion in each sub-
category of each forum were collected into a list (one for
each forum), containing thread title and number of
posts. Threads unrelated to NPS were removed. Each list
was sorted by number of posts to find the threads most
discussed in each forum. We labeled these threads
“post-frequent” for future reference. The top 20 threads
from each forum (a total of 60) were selected for further
investigation and analysis. The total number of posts
from all three forums was 13,082. All collected posts
were in the English language. The gathering of data took
place during October 2013, and the latest retrieved post
was written October 22.
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The 60 discussion threads were analyzed individually by
reading all posts in each of them in pursuit of recurrent
topics of discussion. The analysis process was character-
ized by openness and a bias-free attitude and was under-
taken through a systematic exploration of discussion
topics and patterns in each thread. More specifically,
each post was examined and interpreted for its under-
lying topic. Every time a new topic emerged in each spe-
cific thread, a code was created and related to that
thread. For example, the thread titled “Big n Dandy 2-FA
(2-fluoroamphetamine) thread” contained the following
post: “I used this substance for the first time and experi-
enced chest pains and aches all over the body”, which
was coded as “Sharing experienced side effects”. Further-
more, the thread titled “Dose - The true Methylone dosage?”
contained the post “My recommendation is wrapping 150-
200 mg of Methylone in a rolling paper and ingest it on
empty stomach”, which was coded as “Dosage suggestion”
and “Administration suggestion”. The coding was done
manually in a Word document. Eventually, all 60 discus-
sion threads had a set of codes and multiple accompanying
quotations to support the codes. Also, the codes were re-
peatedly checked for consistency through confirmation by
comparison with other posts on the same topic in the same
thread. On occasion, previously coded threads were re-
read as new topics emerged in other threads, which could
have been missed. At one point, the codes were saturated,
meaning no new topics emerged, which was interpreted as
indicating that the largest part of discussion topics was
covered by the analysis. Next, codes with coherent mean-
ing were arranged into 51 categories (see Table 1). Finally,
all the categories were combined into four overarching
themes that characterized the discussions: (1) uncovering
the substance facts, (2) dosage and administration, (3) sub-
jectively experienced effects, and (4) support and safety.
Ethical considerations
Our research involved the collection and analysis of
already existing information that were published on public
Internet forums. No terms of access or special permissions
restricted the discussions from public access. A discrete
and observational approach was undertaken, and no inter-
actions or interventions with forum discussions or mem-
bers were made. The information available was therefore
considered to be an observation of public behavior online,
in compliance with the ethical guidelines and recommen-
dations provided by SACHRP [29]. In order to further
strengthen the anonymity of the forum members, we
stripped the data set from user aliases and URLs. Also, a
careful assessment of anonymity and search engine visibil-
ity for every presented quotation was undertaken before
publishing. Certain quotation details have been altered in
order to further protect the users’ anonymity.Results
The analysis of post-frequent and drug-related discus-
sions on international Internet forums generated 51 cat-
egorized topics based on 13,082 user posts, which were
combined into four overarching themes of discussion:
(1) uncovering the substance facts, (2) dosage and ad-
ministration, (3) subjectively experienced effects, and (4)
support and safety. The themes are presented below with
some representative quotations.
Uncovering the substance facts
This theme incorporates the users’ discussions about
specific NPS and their objective properties and appear-
ance. A wide variety of known NPS, such as different
types of synthetic cannabinoids, stimulants, dissociatives,
and hallucinogens, were discussed. See Table 2 for a full
list of NPS found in the thread titles of this study. There
were also discussions about branded NPS in which the
actual psychoactive component was concealed or un-
known, which resulted in elaborate speculations about
the content: “Vendor will not reveal the molecule”. / “I
have used both chemicals and believe they are different.
‘Sunshine’ is not Methylone either”. It was very common
to compare the NPS discussed with traditional counter-
part drugs or previously occurring NPS and rate them
accordingly. Another recurring topic was how and where
a substance was acquired: “I really want to try this, could
anyone post where to get it?” to which another user
responded: “Hello, you have an email”. Selling drugs via
the forums or linking to sites that offered drugs was offi-
cially not allowed, so these discussions were mostly
moderated or continued nonpublicly: “Can someone pm
[Personal Message] me a vendor in the US?” Different
vendors were nevertheless mentioned in talks about
their offered products or in discussions related to price,
shipping, and the overall evaluation of the vendors’ ser-
vice. General discussions about NPS availability were
also found, which often included descriptions of where
the NPS was encountered, such as online or in real life.
In addition, the reports of availability were closely linked
to discussions of the legal status in different countries:
“Canada’s drug act does not list Ethylphenidate, and no
analog law for Methylphenidate exists so you should be
legally safe here”. Potentially legal consequences of pos-
session or purchase of NPS were also mentioned.
Other more in-depth substance talk involved chemistry
and pharmacology. Users speculated about how sub-
stances were built molecularly and how specific chemicals
interacted with the brain and body to produce certain ef-
fects, for example, “Both stereoisomers are most likely ac-
tive (as with amphetamine). In that case, it’s a matter
preference: dopaminergic or noradrenergic effects. Choose
for yourself”. The origin and history of certain NPS were
discussed as well. Furthermore, users talked about how
Table 1 The 51 categorized topics and the four
overarching themes characterizing the discussions
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with both traditional substances and other NPS. Related
to pharmacology was the topic of tolerance from repeated
use of the same substance and cross-tolerance between
chemically similar substances. Toxicity was also found to
be of interest for the users, and many discussions focused
on theoretical speculation of a substance’s overall harm
potential: “The neurotoxicity of 4-Fluoroamphetamine de-
rive from the release of large amounts of serotonin from
the neuron, as well as general inhibiting effects of neuronal
processes”. Moreover, discussions focused on the exterior
appearance of different NPS and the assessed purity. Users
described if the NPS was produced in the form of a pill,
powder, or other. The users gave detailed reports on ap-
pearance, feel, smell, and taste. They also assessed the
identity, quality, and purity from the appearance, for ex-
ample, “My powder has a distinct benzene-like chemical
odor and a blueish/greenish color. Unlike former yellowish
odorless batches, I think this one might have impurities”.
Dosage and administration
This theme consists of topics related to circumstances
surrounding the administration of NPS. Dosage was
found to be a widely debated topic of discussion. Many
opinions and estimations about dosing and re-dosing
were stated. Users also asked for advice on specific dose
recommendations with regard to individual traits as pre-
vious experience, body weight, built-up tolerance of the
drug, etc. They also speculated about how the dose
could affect the experience and intensity of effects and
suggested different doses for specific purposes, for ex-
ample, “I think 15 mg is perfect for moderate effects -
great for watching movies! Then at 30 mg the visual im-
pressions and euphoria increase dramatically”. The route
of administration was given much attention. Users de-
scribed several different ways in which different NPS
were taken, such as nasally, intravenously, and orally.
Opinions about the best way to ingest a specific sub-
stance were very common: “I don’t recommend insuffla-
tion and the taste is awful. Rectal administration is
recommended for a rapid onset”. Technical talk about
Table 2 The NPS found among the thread titles
NPS Discussion thread first started Reported to the EMCDDA for the first time
AMT, αMT, alpha-methyltryptamine November 2001 2001
5-MeO-MiPT September 2003 September 2005
4-FA, 4-fluoroamphetamine March 2004 December 2008
2C-E July 2004 Not found
5-MeO-DALT September 2004 February 2007
4-AcO-DMT August 2006 August 2009
Methylone September 2006 March 2005
MDPV, methylenedioxypyrovalerone October 2006 December 2008
Mephedrone December 2007 March 2008
HOT-7 March 2008 Not found
Spice (JWH-018) November 2008 December 2008
3-MeO-PCP July 2009 March 2012
Methoxetamine September 2009 November 2010
6-APB, benzo fury May 2010 June 2011
Ethylphenidate July 2010 November 2011
25D-NBOMe September 2010 April 2012
AM-2201 October 2010 January 2011
MPA, methiopropamine December 2010 Not found
25I-NBOMe January 2011 June 2012
Allylescaline February 2011 July 2013
BZ-6378 April 2011 November 2011
a-PVP November 2011 April 2011
AH-7921 December 2011 August 2012
AL-LAD December 2011 Not found
2-FMA, 2-fluoromethamphetamine February 2012 March 2012
MDME February 2012 Not found
Pyrazolam July 2012 August 2012
N-Ethyl-norketamine August 2012 September 2012
5-MAPB December 2012 January 2013
4,4-Dimethylaminorex May 2013 October 2013
The substances appeared on the forum before reported to the EMCDDA in all except one case. Five substances were not found in the lists published by EMCDDA
and therefore not compared.
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ing and purification of a substance were found: “Did you
wash the crystals before recrystallization? If so, which
solvent(s) did you use?” Taking a specific NPS in combin-
ation with other drugs and how the different effects
would interact with or supplement each other were also
discussed: “I want to experience Methylone, Mephedrone
and MDPV in one go. Who has tried this or can give ad-
vice on dosage?” The circumstances and surroundings in
which the drugs were administered were shared among
users. They also asked for, or proposed to others, several
settings and recreational activities: “How would this sub-
stance suit a nightclub setting?” Users also discussed
their expectations of the upcoming experience of NPSand their mood or state of mind when taking the drug.
They were suggesting and sharing different purposes of
using drugs, for example, study aid, recreation, self-
medicating, curiosity, and personal development.
Subjectively experienced effects
This theme was the most prevalent and summarizes dis-
cussions about subjective and self-experienced effects in-
duced by a wide variety of NPS. The effects were
discussed in great detail and with precision. Many initial
or onset effects were described. Also, the primary effects
and positive aspects of an experience were shared thor-
oughly: “I felt a boost in confidence and was more social,
verbal and energized. I was also more curious and
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and recurring topics in this theme. Specification of the
time at which different phases of the experience oc-
curred was mentioned. The discussions of effects were
found to consist of physiological, emotional, and cogni-
tive aspects of the experience. Also, users were talking
about perceptual and sensory alterations. In addition to
the positive effects, many side effects or negative experi-
ences were shared: “I used this substance for the first
time and experienced chest pains and aches all over the
body”. Residual effects or aftereffects were also given at-
tention in the discussions. Users who had not tried a
specific NPS asked others to share their experienced ef-
fects. There were not many debates or arguments found
among the effect discussions; instead, it appeared that
the whole community contributed to complete a picture
of the overall effects: “I also experienced that the ‘magic’
of Methoxamine decreased over several successive trips”.
The first posts about experiences with a novel substance
were often scientifically depicted: “T + 0:00 2 mg allergy
check intranasally. T + 0:22 Calibration dose 15 mg
sublingually. T + 1:10 Subject experiences euphoria
equivalent to 40 mg 4-methylephedrone but less stimu-
lation. T + 2:10 Subject confirms a return to baseline.”
References to, and comparisons with, traditional sub-
stances and their effects were made to explain the ex-
perience to others: “4-fluoroamphetamine definitely feels
like MDMA. The empathy is there and I’m socializing and
experiencing a pleasant wellbeing. The stimulation and
sharp focus also reminds me of amphetamine”. In addition,
if the NPS in focus had a traditional counterpart sub-
stance, it was often used as point of reference to evaluate
the effects at large. Rating and evaluation of effects in gen-
eral were found to be a very common topic: “I love it!
Although it does not have the intensity of MDMA or
Mephedrone, it reminds me of their chemicals qualities.
This substance is deeper and more multifaceted than am-
phetamine”. They also discussed the impact of the experi-
ence on everyday life: “6-MAPB changed my worldview
and helped me in a tremendous way”.
Support and safety
This theme emphasizes that the discussions involved
social support and community help with drug-related
issues of concern. Users often asked each other for spe-
cific advice on how to prevent or minimize harm. They
also expressed the need for support with drug-related
problems, to which other users would respond: “I ad-
vise you not to take it under those circumstances be-
cause serotonin will be released like with MDMA”. It
was also found that users shared practical tricks and
theoretical knowledge with one another to reduce poten-
tial problems such as sleep deprivation, contraindications,
and the misidentification of substances. Experienced userswere asked to verify the authenticity of substances by pro-
viding photographs or appearance descriptions. Further-
more, general caution and harm reduction was proposed
throughout the forums: “At this forum we advocate taking
a break of at least one month between uses, which applies
to 5-MAPB as well”. Individual users who suspected a
dangerous aspect of using a NPS cautioned the whole
community. The first users who ordered and used a previ-
ously unknown NPS shared their firsthand experience of
immediate risks and hazards with the rest of the commu-
nity. For example, several early warnings about substances
or combination of substances that constituted a perceived
risk were found: “Purple Wave of any kind is toxic… do
not purchase it, you will mess yourself up”. / “Be aware of
this combo! Some people have had strong reactions to this”.
Less immediate warnings of potential side effects accumu-
lated in the threads of discussion as more users started to
report back about the drug: “I warn you: the residual ef-
fects are bad if you binge on it for a while and abruptly
stop”. The abuse potential of different drugs was also dis-
cussed: “In my experience it has highly addictive proper-
ties”. Furthermore, if the first users of an unknown NPS
experienced it as safe and reliable, it was reported in the
thread as well. Warnings also included notions of bad
batches of a substance or scamming vendors.
Discussions were oriented towards acute help and
emotional support to users who were online to ask for
guidance while intoxicated with fearful or bad reactions:
“Is anyone online because I need assistance with an on-
going anxiety attack?” Different coping strategies were
suggested by fellow users: “Relax, you will be fine. Put on
a movie or occupy yourself by talking to friends.” Long-
term problems like addiction and withdrawal were also
topics that emerged. Users asked about abuse problems,
and others were being supportive or offered their experi-
ence on how to solve them. Also, several recovery reports
were shared publicly to other users, who responded with
encouraging comments or grateful remarks.
Discussion
This study has explored and characterized the discus-
sions about NPS on international Internet forums. The
most post-frequent discussion threads from three “lead-
ing edge” international Internet forums were systematic-
ally analyzed for recurring topics. Fifty-one categories of
discussion emerged, which were combined into four
overarching themes that characterized the discussions:
(1) uncovering the substance facts, (2) dosage and ad-
ministration, (3) subjectively experienced effects, and (4)
support and safety. The findings indicate that the discus-
sions involved an extensive exchange of knowledge
about NPS and how to use them safely. The discussions
were characterized by a communal process in which
forum users supported each other and contributed with
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thread of discussion brought awareness to a previously
unfamiliar substance of interest. More specifically, the
initial and continuous characteristic of this generative
process was to uncover the substance facts, which incorpo-
rated elaborate theoretical speculation of origin, classifica-
tion, and molecular structure, as well as pharmacological
action, tolerance, and toxicity. Many users displayed a very
high level of knowledge, which reflects a dedicated interest
in NPS as well as a focus on preparation and safety. The
accuracy of single posts of information is difficult to assess
since reliable knowledge about these substances is scarce.
The general principles of toxicology and pharmacology
were however appropriately followed. More interesting
is that every post contributed to a greater body of cu-
mulative community knowledge which could be pub-
licly assessed and continuously refined by anyone on
the forum. Another interesting finding is that discus-
sions occasionally focused on revealing the concealed
or unknown psychoactive constituents in branded NPS
with content specification intentionally left out. When
possible, the actual appearance was used for identifica-
tion and assessment of quality. As information about a
NPS increased, and comparisons with similar types of
substances were made, an overall assessment of ex-
pected effects and potential risks and benefits started to
form. By then, the users also discussed both the legal sta-
tus in different parts of the world and the availability and
acquisition of the NPS. In addition, different vendors were
evaluated for their customer service and quality of prod-
uct, indicating the awareness of safe drug use.
As the uncovering of facts progressed, expectancies of
the actual NPS started to emerge, and the process of in-
formation exchange was further characterized by an
added focus on dosage and administration. In short,
users discussed virtually everything that was related to
the knowledge of getting the drug into the body. Per-
sonal preferences and different individual conditions
gave rise to many opinions and suggestions. Further-
more, effect- and purpose-specific dosing and method of
administration were thoroughly requested and provided
by users, so were different sets and settings in which the
use of drugs occurred, as well as do-it-yourself tech-
niques for enhancement of administration. Discussions
about ingesting a combination of drugs for supplemen-
tary and interactive effects were also frequently dis-
cussed. The majority of these topics correspond to
discussion characteristics found among a sample of on-
line ecstasy users [30], which not only add support to
the present study but also indicate that the result apply,
at least partly, to online drug discussions in general.
Gradually, numerous and very detailed descriptions of
subjectively experienced effects started to characterize the
discussions, which was interpreted as an expression of asubstance’s increased availability and popularity over
time. Self-reports of firsthand experienced effects were
very common and constituted the most prevalent theme.
A whole spectrum of effects, as well as potency and dur-
ation, were depicted and shared with the community in
a precise and technical manner. The connoisseur-like ac-
counts of experience contributed to the value of using
Internet discussions as a source of detailed data for sci-
entific studies where triangulation is required or relevant
data are scarce. Users were inclined to review and rate
their experience, as well as compare it with effects of the
NPS’s traditional counterpart drug. In addition, the de-
scriptions of experiences were cumulative and appeared
to generate a consensual evaluation of a substance’s use-
fulness. This might help explain why some NPS become
more popular and widely spread than others. Interest-
ingly enough, the users emphasized both positive and
negative experiences of effects, which indicate that the
reports were retold with a thorough and comprehensive
ambition. In earlier studies based on self-reported data
[21-23], it was suggested that experiencing per se was
more important than the actual content of the experience
(fear or euphoria), which offers an explanation for the high
prevalence of nuanced and balanced descriptions.
The findings in the present study provide an additional
explanation to the absence of one-sidedly positive and
drug romanticizing discussions, namely that users were
concerned with the support and safety of themselves and
others. The result showed that the discussions were
served as a user-governed early warning system where,
for example, acute risks and side effects were posted
whenever a dangerous or unhealthy aspect of a NPS was
encountered. Furthermore, the discussions were charac-
terized as a support system where different types of indi-
vidual concerns were responded to with advice, practical
tricks, and knowledge in order to prevent and minimize
harm. In fact, harm reduction appeared both explicitly
and implicitly as the common denominator that on the
whole permeated the discussions. At a higher level of ab-
straction, harm reduction emerged as a characteristic
that was present in all themes in this study. The signifi-
cance of harm reduction is further supported by the find-
ings in previous studies where drug-related discussion
forums have been examined [27,28,30]. However, publicly
available discussions have at least two conceivable flip
sides. First, Barratt et al. [31] have revealed a less acknowl-
edged and oppositional discourse to harm reduction which
incorporates a desire for dangerous drug use and downplay
of harm reduction. This alternative discourse was not re-
vealed by the present study. Nonetheless, the present study
exposed another possible flip side: uncovering the sub-
stance’s facts will, apart from reducing harm by minimizing
uncertainty and unpredictability, potentially result in pub-
licly available knowledge about, e.g., acquisition of a drug.
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dence [32] indicates that exposure to drug information
does not have counterproductive effects. Nevertheless, this
dilemma highlights the previously debated issue [28,33]
whether the focus on prevention should be a reduction in
overall use or harm. In any case, the present study showed
that the extensive and cumulative process of knowledge ex-
change and social support enabled by Internet discussion
forums offers valuable insight of use to prevention strat-
egies aiming at a reduction of harm. All except one of the
substances found in the thread titles appeared as an online
discussion before reported to the EMCDDA (see Table 2).
The forums could therefore be used for quicker monitor-
ing and risk profiling. Internet forums are not only an
undervalued location for drug prevention; further research
should take greater advantage of the publicly available in-
formation to investigate new drugs, their effects, and the
motivation for using them.
Conclusions
Discussions on drug-related Internet forums were charac-
terized by a communal process in which users supported
each other and exchanged an extensive and cumulative
amount of knowledge about previously unfamiliar sub-
stances. The discussions uncovered the substance facts
such as identity, origin, quality, legal status, acquisition,
and pharmacology. Users also talked about circumstances
related to the administration, including intentions, set-
tings, individual dosing, safe combination of drugs, and
administration techniques. Furthermore, a plethora of
subjectively experienced effects were shared among users
in a connoisseur-like manner. These reports were nuanced
and comprehensive, which was suggested to reflect the
users’ concern for support and safety. On the whole, harm
reduction emerged as the main characteristic that perme-
ated the discussions. In addition, users warned each other
about potential risks and side effects and supported each
other with advice and guidance. The findings in the
present study contribute to the understanding of the on-
line reality that faces youth in search of drug-related infor-
mation. Also, the discussion forums could be used for
drug prevention, as well as a source of information for fur-
ther research about NPS.
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